Page last updated: 2024-11-03

propofol and Mastocytosis

propofol has been researched along with Mastocytosis in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgeat, A1
Ruetsch, YA1

Other Studies

1 other study available for propofol and Mastocytosis

ArticleYear
Anesthesia in a patient with malignant systemic mastocytosis using a total intravenous anesthetic technique.
    Anesthesia and analgesia, 1998, Volume: 86, Issue:2

    Topics: Adult; Chymases; Female; Histamine; Humans; Infusions, Intravenous; Mastocytosis; Propofol; Serine E

1998